Search with one or more keywords


This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.


xml
XML

Export to XML

Please choose the format :

pdf
PDF

Export to PDF

Which version do you want to export ?

csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Covid-19 : 84 forms

Sorting of results :

COVIDET - Evaluation of SARS-CoV-2 seroprevalence among prison inmates

Head : Mellon Guillaume

Version 1
Overview

7

Last update : 05/05/2021

COVIDET - Evaluation of SARS-CoV-2 seroprevalence among prison inmates

Head : Mellon Guillaume

Main objective

Evaluate the prevalence of SARS-CoV-2 infection among prison inmates in detention institutions in the Ile-de-France region, by measuring SARS-CoV-2 antibody levels in plasma

Inclusion criteria

Subjects fulfilling all of the following criteria will be included in the study:
o Female inmates on the lists provided by the detention institutions or male inmates randomly selected from the lists provided by the detention institutions.
o Aged 18 to 80 years.
o Freely given, informed consent form signed.

COVIDIV - Collateral damage of the COVID-19 pandemic observed among patients receiving treatment with intravitreal (IVT) injections of antiangiogenic agents

Head : Mauget-Faÿsse Martine

Version 1
Overview

8

Last update : 04/21/2021

COVIDIV - Collateral damage of the COVID-19 pandemic observed among patients receiving treatment with intravitreal (IVT) injections of antiangiogenic agents

Head : Mauget-Faÿsse Martine

Main objective

Describe the changes in visual acuity among patients receiving treatment with repeat IVT injections of antiangiogenic agents during the COVID-19 epidemic, between September 2019 and May 2021

Inclusion criteria

Patient aged 18 years and over
-Eye disorder requiring treatment with repeat IVT injections of antiangiogenic agents: Exudative ARMD, macular oedema associated with diabetes or secondary to retinal vein occlusion.
-Initiation of treatment with repeat IVT injections before 01/10/2019

BBCovid - Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses

Head : CARROUEL Florence, Laboratory "Systemic Health Course", EA4129

Version 1
Overview

9

Last update : 01/06/2021

BBCovid - Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses

Head : CARROUEL Florence, Laboratory "Systemic Health Course", EA4129

Main objective

Change from Baseline amount of SARS-CoV-2 in salivary samples at 7 days
Quantitative PCR experiments will be performed and a quantitative analysis of the salivary samples will be made

Inclusion criteria

• Age: 18-70 years
• Clinical diagnosis of Covid-19 infection by the patient's general practitioner and hospital doctor
• Clinical signs started less than 48 hours ago.
• Virological confirmation: not necessary but possible.
• Understanding and acceptance of the trial.
• Written agreement to participate in the trial

COVIDonneur - SARS-CoV-2 seroprevalence study in the blood donor population

Head : Gallian Pierre, Emerging Viruses Units, 20-21 Boulevard Jean Moulin, 13005 Marseille

Version 1
Overview

10

Last update : 05/06/2021

COVIDonneur - SARS-CoV-2 seroprevalence study in the blood donor population

Head : Gallian Pierre, Emerging Viruses Units, 20-21 Boulevard Jean Moulin, 13005 Marseille

Main objective

Estimate the seroprevalence of SARS-CoV-2 infection in the French blood donor population (18-70 years) in different geographical zones (mainland France and overseas departments), at different times in the epidemic, so as to model the progression of the epidemic

Inclusion criteria

Accepted blood donors
aged 18 to 70 years.
in the geographical zones of interest
having agreed to the use of their samples for research

Plasma samples > 500 µL in volume

CONFIMIDs - Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology)

Head : DEZOTEUX Frédéric, INSERM U1286 INFINITE

Version 1
Overview

11

Last update : 05/05/2021

CONFIMIDs - Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology)

Head : DEZOTEUX Frédéric, INSERM U1286 INFINITE

Main objective

Estimate the frequency of patients, with chronic inflammatory disorders, followed up as part of the FHU IMMINeNT project (gastroenterology, rheumatology, dermatology, pulmonology, neurology, internal medicine), whose follow-up has been affected by the lockdown and easing of restrictions.

Inclusion criteria

All adult patients followed up as part of the FHU project for:
- Chronic inflammatory bowel disease or IBD (Crohn’s disease and
ulcerative colitis),
- Rheumatic disorders (rheumatoid
arthritis and spondyloarthritis)
- Multiple sclerosis
- Asthma
- Psoriasis
- Atopic dermatitis
- Systemic auto-immune disease (scleroderma and lupus)

COVID-PRO-IMPACT - impact of the COVID-19 pandemic on the psychological quality of life of healthcare professionals

Head : CHENE Gautier, Hôpital Femme Mère Enfant

Version 1
Overview

12

Last update : 04/06/2021

COVID-PRO-IMPACT - impact of the COVID-19 pandemic on the psychological quality of life of healthcare professionals

Head : CHENE Gautier, Hôpital Femme Mère Enfant

Main objective

Study the evolution of the psychological quality of life of healthcare professionals during the confinement period linked to the COVID-19 pandemic

Inclusion criteria

person over 18
person exercising a profession in the field of health
person who expressed his non-opposition

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here